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Abstract	
Critical	criminology	repeatedly	has	drawn	attention	to	the	state‐corporate	nexus	as	a	site	of	
corruption	and	other	forms	of	criminality,	a	scenario	exacerbated	by	the	intensification	of	
neoliberalism	 in	 areas	 such	 as	 health.	 The	 state‐pharmaceutical	 relationship,	 which	
increasingly	 influences	 health	 policy,	 is	 no	 exception.	 That	 is	 especially	 so	 when	
pharmaceutical	 products	 such	 as	 vaccines,	 a	 burgeoning	 sector	 of	 the	 industry,	 are	
mandated	 in	 direct	 violation	 of	 the	 principle	 of	 informed	 consent.	 Such	 policies	 have	
provoked	suspicion	and	dissent	as	critics	question	the	integrity	of	the	state‐pharma	alliance	
and	its	impact	on	vaccine	safety.	However,	rather	than	encouraging	open	debate,	draconian	
modes	of	governance	have	been	implemented	to	repress	and	silence	any	form	of	criticism,	
thereby	protecting	the	activities	of	the	state	and	pharmaceutical	industry	from	independent	
scrutiny.	 The	 article	 examines	 this	 relationship	 in	 the	 context	 of	 recent	 legislation	in	
Australia	 to	 intensify	 its	 mandatory	 regime	 around	vaccines.	 It	 argues	 that	 attempts	 to	
undermine	freedom	of	speech,	and	to	systematically	excoriate	those	who	criticise	or	dissent	
from	mandatory	 vaccine	 programs,	 function	 as	 a	 corrupting	 process	 and,	 by	 extension,	
serve	 to	 provoke	 the	 notion	 that	 corruption	 does	 indeed	 exist	within	 the	 state‐pharma	
alliance.	
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Introduction	
	
…	strong	control	over	key	processes	combined	with	huge	resources	and	big	profits	
to	 be	 made	 make	 the	 pharmaceutical	 industry	 particularly	 vulnerable	 to	
corruption.	(Transparency	International	2016)	
	
Influence	is	not	that	easy	to	measure.	But	one	metric	that	can	point	toward	relative	
influence	is,	simply,	money.	And	in	that	context,	pharmaceuticals	have	few	peers.	
(Fields	2013:	559)		
	
The	article	examines	corruption	within	the	state‐corporate	nexus	as	it	relates	to	vaccines	and	the	
‘pharmaindustry’;	that	is,	the	networks	of	industry,	medical	and	political	actors	involved	in	their	
research,	manufacturing,	regulation	and	dissemination.	It	argues	that	the	structure	and	conduct	
of	 these	 alliances	 operate	 as	mechanisms	of	 control,	 stymieing	open	debate	 and	 independent	
inquiry	 around	 the	 safety	 and	 efficacy	 of	 vaccines.	 This	 is	 especially	 concerning	 given	 the	
mandated	status	of	vaccines	in	countries	such	as	Australia,	and	the	violation	of	‘informed	consent’	
by	policies	 that	 require	medical	 intervention.	The	 article	 further	 contends	 that	 the	neoliberal	
regime	within	 which	 these	 alliances	 are	 nurtured	 facilitates	 draconian	modes	 of	 governance	
through	which	criticism	of	mandated	vaccination	is	repressed	and	silenced,	thus	protecting	the	
activities	 of	 the	 state	 and	 pharmaceutical	 industry	 from	 independent	 scrutiny.	 Undermining	
freedom	 of	 speech,	 freedom	 of	 information	 and	 freedom	 of	 conscience	 not	 only	 becomes	 a	
corrupting	process	in	itself,	with	these	cherished	societal	values	deemed	increasingly	redundant,	
but	 also	 infers	 the	 presence	 of	 actual	 corruption	 within	 these	 alliances	 through	 the	 lack	 of	
transparency	and	debate.	The	article	does	not	 focus	on	vaccine	 safety	and	efficacy	per	 se	 but,	
rather,	in	acknowledging	that	state	and	corporate	bodies	are	‘key	and	central	agents	of	power	in	
contemporary	 societies’	 (Whyte	 2009:	 3)	 seeks	 to	 interrogate	 the	 nature	 and	 impact	 of	 this	
relationship	on	this	contentious	area	of	public	health.		
	
Corruption	and	the	pharmaindustry	
Broadly	understood,	corruption	is	a	deviation	from	the	norms	of	exchange	involving	the	abuse	of	
power	for	financial	or	non‐financial	gain	(Bridenthal	2013;	Gounev	and	Ruggiero	2012;	Ledeneva	
1998;	 Punch	 2009;	 Wedel	 2001,	 2003).	 Transparency	 International	 (TI),	 one	 of	 the	 major	
watchdogs	of	corruption	worldwide,	defines	 it	 in	general	 terms	as	 ‘abuse	of	entrusted	power’	
specifically	in	relation	to	public,	rather	than	private,	office	(Transparency	International	2016).	
Others	extend	the	definition	to	 incorporate	the	private	sector,	 including	practices	that	are	not	
necessarily	 illegal	 (Naylor	 2004;	 Sutherland	 1983).	 TI’s	 cautious	 approach	 to	 corruption	 as	 a	
perception	reflects	the	cultural,	political	and	social	ambiguity	of	the	term,	making	a	consensus	
around	 definition	 especially	 challenging.	 Holmes	 suggests	 that	 the	 morass	 of	 variables	
encompassing	a	definition	of	corruption	‘should	not	blind	us	to	the	fact	that	some	actions	are	seen	
as	corrupt	 in	most	 if	not	all	societies’	 (Holmes	1993:	63).	Nonetheless,	 the	 ideological	context	
within	which	corruption	occurs,	and	the	extent	to	which	it	becomes	instrumental	in	maintaining	
the	 status	 quo,	 plays	 a	 crucial	 role	 in	 how	 it	 is	 understood	 and	 responded	 to,	 making	 the	
distinction,	 for	 example,	 between	 political	 donations	 and	 bribery,	 normative	 rather	 than	
ontological.		
	
The	 pharmaceutical	 industry	 (pharmaindustry)	 is	 no	 stranger	 to	 corruption.	 Bribery,	
compromised	drug	quality,	conflict	of	interest,	fraud	and	price‐fixing	constitute	part	of	a	litany	of	
its	 illegal	 practices	 and	 unethical	 behaviour,	making	 it,	 historically,	 one	 of	 the	most	 frequent	
corporate	violators	of	the	law,	alongside	the	oil	and	auto	industries	(Braithwaite	1984;	Clinard	
and	 Yeager	 1980;	 Dukes,	 Braithwaite	 and	 Moloney	 2014).	 Recent	 scandals,	 in	 which	
pharmaceutical	giants	such	as	GlaxoSmithKline,	Pfizer	and	Merck,	have	faced	fines	running	into	
millions	of	US	dollars	for	serious	lawbreaking,	are	indicative	of	the	level	of	harm	their	behaviour	
poses,	and	the	pattern	of	recidivism	that	has	branded	the	industry	 ‘recalcitrant’	and	willing	to	
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employ	‘illegal	inducements	as	a	core	business	strategy	for	selling	its	prescription	drugs’	(Kelton	
2013).		
	
The	ubiquity	of	criminal	behaviour	in	the	phamaindustry	was	the	subject	of	John	Braithwaite’s	
1984	seminal	text,	Corporate	Crime	in	the	Pharmaceutical	Industry,	which	uncovered	a	culture	of	
bribery,	 conflict	 of	 interest	 and	 almost	 derisory	 ineffective	 punitive	 responses	 to	 crimes	 and	
harmful	practices	that	cost—as	they	continue	to	do—the	lives	of	thousands.	Despite	his	optimistic	
conclusion	 that	 the	pharmaindustry	was	 at	 an	 ethical	 turning	point,	Braithwaite,	with	 his	 co‐
authors,	was	forced	to	conclude	in	the	2014	publication	Pharmaceuticals,	Corporate	Crime	and	
Public	Health	that:	‘Corporate	crime	within	the	pharmaceutical	industry	appears	to	be	on	the	rise’	
(Dukes,	Braithwaite	and	Moloney	2014:	281).	Still	hopeful	of	the	possibility	of	encouraging	a	form	
of	ethical	capitalism,	they	propose	a	number	of	innovative	regulatory	strategies	in	the	belief	that	
corporations,	given	the	right	environment,	will	self‐regulate	or	respond	to	bespoke	applications	
of	a	regulatory	carrot	and	stick.	But,	as	Tombs	and	Whyte	claim,	and	as	evinced	by	the	constant	
infractions	 of	 law	 by	 pharmaceutical	 companies,	 corporations	 are	 intrinsically	 criminal,	
pathological	 entities	whose	harmful	 behaviours	 are	given	 impetus	 through	 ‘the	permission	of	
governments,	 or	 even	 at	 the	 behest	 of	 governments’	 (Tombs	 and	 Whyte	 2015:	 18).	 The	
oxymoronic	notion	of	‘ethical	capitalism’,	as	in	‘corporate	social	responsibility’,	is	a	convenient,	if	
unintended,	distraction	away	from	the	cold	reality	that	corporations	cannot	behave	with	integrity	
if	they	wish	to	survive	in	any	form	of	capitalist	society,	duty	bound	as	they	are	(and	legally	so	
under	 US	 law)	 to	 profit	 maximisation	 in	 the	 interests	 of	 shareholders	 rather	 than	 those	 of	
consumers,	irrespective	of	whether	their	business	is	health	or	war.	
	
From	sinner	to	saint	
Tainted	by	a	history	of	corrupt	practices,	the	pharmaindustry,	nonetheless,	continues	to	wield	
influence	 and	 expand	 the	 reach	 of	 its	 commercial	 activities,	 buoyed	 by	 the	 increasing	
‘phamamedicalisation’1	 of	 health	 delivery.	 A	 crucial	 aspect	 of	 this	 expansion	 is	 the	 industry’s	
growing	influence	in	public	health,	 in	particular,	primary	prevention:	that	is,	the	promotion	of	
health	and	prevention	of	disease	by	reducing	susceptibility	to	disease.	One	of	the	most	common	
forms	of	primary	prevention	is	vaccination.	While	vaccines	have	become	a	symbol	of	hope	in	the	
fight	against	disease,	 they	have	also	 sparked	controversy,	deeply	dividing	opinions	as	 to	 their	
efficacy,	safety	and	even	necessity	(SBS	2015).		
	
Despite	 this	 history,	 attempts	 to	 question	 the	 integrity	 of	 the	 pharmaindustry	 in	 regard	 to	
vaccines,	whether	by	the	medical	profession	or	the	lay	public,	are	consistently	met	with	hostile	
responses.	Framed	within	a	simplistic	and	misleading	dichotomy	between	the	pro‐vaccine	lobby	
and	so‐called	‘anti‐vaxxers’,	thus	leaving	no	room	for	more	nuanced	voices	which	support	some	
vaccines	but	are	concerned	about	issues	such	as	over‐vaccination	(Hart	2017),	or	caution	over	
the	 levels	 of	 toxicity	 in	 adjuvants,2	 any	 form	 of	 criticism	 is	 labelled	 as	 emotional,	 dangerous,	
hysterical	and	unscientific	(Jaret	2016).	Individuals	voicing	their	concerns	have	found	themselves	
vilified	in	the	media,	shunned	by	members	of	the	public	and	excluded	from	areas	of	social	life,	
including	the	workplace	(Bertrand	2015).	This	stands	in	stark	contrast	to	the	concerns	expressed	
over	 the	 safety	 issues	 of	 prescription	 drugs	 such	 as	 Vioxx	 and	 Paxil,	 which	 have	 led	 to	
investigations	 into	 and	 successful	 lawsuits	 against	 irregularities	 by	 the	 pharmaindustry	
(Goldacre	 2012;	 Griffin	 and	Miller	 2011),	 and	 the	 ineffectiveness	 and	 overuse	 of	 many	 anti‐
depressants	(Gotzsche	2013;	Healy	2012).		
	
No	medical	intervention	is	100	per	cent	safe,	vaccines	included.	In	1988	the	US	government	set	
up	the	National	Vaccine	Injury	Compensation	Program	(VICP),	which	has	paid	out	approximately	
US$3.6	billion	to	claimants	since	its	inception	and	up	until	2015	(Health	Resources	and	Services	
Administration	2017).	 The	UK’s	Vaccine	Damage	Payment	 Scheme,	 created	 in	 1979,	 provides	
compensation	to	vaccine‐harmed	victims	and	their	families,	amounting	to	£3.5	million	pounds	
between	1997	 to	2005	(BBC	2005)	 (to	date,	Australia	does	not	have	a	compensation	scheme,	
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although	discussions	are	underway	regarding	its	eventual	establishment).	The	very	presence	of	
such	 schemes	 confirms	 that	 vaccines	 carry	 risk,	 yet	 the	 rhetoric	 and	 actions	 of	 the	
pharmaindustry	not	 only	 vilify	 those	who	point	 out	 the	 risks	but,	 in	 some	 instances,	 respond	
punitively	to	those	producing	data	or	expressing	opinions	that	challenge	vaccine	safety	(Yerman	
2011).	One	example	is	the	removal	of	research	papers,	without	any	accompanying	explanation,	
that	produce	negative	data	on	vaccine	safety	from	medical	journals	after	review	and	publication	
(Grant	2016).		
	
Any	mandated	public	 health	 policy	must	 be	 open	 to	 constant	 scrutiny,	 independent	 scientific	
inquiry	 and	open	debate.	 Transparency	 is	 particularly	 crucial	when	policies	 involve	 the	 close	
collaboration	between	the	state	as	regulator,	and	the	industry	being	regulated,	not	least	when	the	
industry	 in	 question	 is	 tainted	 by	 a	 history	 of	 corrupt	 practices.	 However,	 as	 critical	
criminologists	have	shown,	the	state‐corporate	nexus	is	itself	a	site	of	constant	harm	production,	
not	only	where	‘ruling	elites	label,	reify,	and	punish	as	criminal	those	interactions	that	counter	
their	 interests’	 (Bridenthal	2013:	4)	but,	conversely,	as	a	means	to	 legitimise,	 through	diverse	
means	of	obfuscation,	harmful	actions	and	dubious	relationships	that	serve	their	mutual	interests	
(Chambliss	1988;	Green	and	Ward	2004;	Kramer	et	al.	2002;	Sutherland	1983).	Buoyed	by	the	
favourable	 conditions	 of	 neoliberalism	 and	 the	 erosion	 of	 a	 clear‐cut	 dichotomy	between	 the	
public	and	private	spheres,	the	state‐pharma	collaboration	is	thus	able	to	operate	with	greater	
levels	 of	 immunity	 from	 accountability	 and	 impunity	 for	 its	 harmful	 activities.	 Thus	 the	
pharmaceutical	industry,	as	a	partner	of	the	state,	is	more	able	to	divest	itself	of	its	tainted	past,	
and	function	as	a	putative	champion	of	citizens	rather	than	an	exploiter.		
	
The	Australia	connection		
In	2015	Australian	states	began	their	rollout	of	the	federal	government’s	‘No	Jab,	No	Play’	policy,	
a	scheme	to	encourage	the	optimum	take‐up	of	childhood	vaccines	including	the	Measles,	Mumps	
and	 Rubella	 (MMR)	 and	 Diphtheria,	 Tetanus	 and	 Pertussis	 (dTpa)	 vaccines.	 While	 a	 similar	
scheme,	 which	 withheld	 access	 to	 a	 number	 of	 government	 rebates	 and	 financial	 assistance	
schemes	from	parents	and	carers	who	refuse	to	vaccinate	their	children,	had	been	in	place	since	
1999,	 this	 latest	 policy	 removed	 exemptions	 on	 the	 grounds	 of	 conscientious	 objection,	 thus	
impacting	on	a	larger	cohort	of	dissenters.	A	similar	change	to	vaccine	policy	was	also	occurring	
in	the	United	States.	Both	countries	have	faced	opposition	to	mandatory	vaccines	from	parents,	
doctors	and	researchers,	with	one	of	the	major	objections	being	that	such	a	policy	violates	human	
rights.	They	point	to	contraventions	of	international	instruments	such	as	Article	6	of	the	UNESCO	
Universal	 Declaration	 on	 Bioethics	 and	 Human	 Rights	 (UDBHR)	 (2005)	 which	 states,	 ‘[a]ny	
preventative,	diagnostic	and	therapeutic	medical	intervention	is	only	to	be	carried	out	with	the	
prior,	 free	 and	 informed	 consent	 of	 the	 person	 concerned,	 based	 on	 adequate	 information’.	
Further,	policies	where	children,	as	the	majority	demographic	for	vaccines,	are	denied	access	to	
education	unless	they	have	been	immunised,	violate	Article	28	of	the	United	Nations	Convention	
on	the	Rights	of	the	Child	(CRC)	(1989),	which	provides	for	access	to	education	being	available	to	
all.	 Even	 those	 openly	 pro‐vaccine	 are	 uncomfortable	 with	 the	 rights	 implications	 raised	 by	
mandatory	medical	intervention,	and	see	it	as	a	form	of	intimidation	and	discrimination	(Gerber	
2013;	Leask	2015).		
	
In	 a	 statement	 issued	by	Victoria	Health	 and	Human	 Services	 (Australia	 has	 ratified	 both	 the	
UDBHR	and	the	CRC)	the	justification	for	mandated	vaccination	is	based	on	a	safety	and	security	
agenda:	 ‘[t]he	 rights	 in	 the	 [Victorian]	 charter	 may	 be	 subject	 to	 reasonable	 limitation.	
Reasonable	 limitation	 involves	 balancing	 the	 rights	 of	 the	 individual	 with	 the	 need	 for	
government	to	protect	the	broader	public	interest	especially	in	relation	to	public	safety,	health	
and	 order’	 (State	 of	 Victoria,	 Health	 and	 Human	 Services	 2016).	 Thus,	 the	 pharmaceutical	
industry,	 in	 similar	vein	 to	 the	 arms	 industry,	has	now	become	a	major	provider	 for	national	
security.	And,	in	an	equally	similar	vein,	national	security	issues	often	trump	human	rights.	
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Further	 objections	 to	 vaccine	mandates	 are	 based	 on	 safety.	 Citing	 cases	 of	 vaccine‐damaged	
children	and	reports	of	adverse	reactions	to	either	the	prepared	virus	and/or	the	adjuvants	(used	
inter	alia	to	enhance	a	particular	immunity	response),	some	opt	to	shoulder	the	risk	of	disease	to	
their	children	rather	than	receive	the	vaccines	(DeNoon	2011).	In	a	study	conducted	in	New	South	
Wales	by	Catherine	Helps,	parents	voiced	concerns	about	vaccine	safety,	qualifying	their	anxieties	
as	a	lack	of	trust	in	the	priorities	of	vaccine	manufacturers:	‘They’re	not	sure	that	the	motivation	
necessarily	comes	 from	the	best	 intentions	 for	 their	child.	There	 is	some	concern	about	 there	
being	profit	motive’	(ABC	News	2016).	Many	of	these	parents,	like	their	US	counterparts	(Saad	et	
al.	2009),	come	from	higher	income	and	tertiary	level	educational	backgrounds.	Their	concerns	
about	 the	 integrity	 of	 the	 industry	 echo	 Transparency	 International’s	 report	 of	 ‘abundant	
examples	globally	that	display	how	corruption	in	the	pharmaceutical	sector	endangers	positive	
health	outcomes’	(2016:	1)	Further,	when	prestigious	 journals	such	as	the	New	Scientist	write	
that	vaccines,	having	been	‘the	unprofitable	runt	of	the	pharmaceutical	family’,	have	now	become	
the	boom	sector	of	an	increasingly	monopolistic	industry	‘unusually	concentrated,	with	80	per	
cent	of	vaccines	supplied	by	just	five	big	companies’	(Mackenzie	2011),	parents’	claims	that	‘best	
intentions’	might	not	be	a	main	priority	appear	entirely	rational	and	justified.		
	
Other	concerns	around	the	state‐pharma	nexus	centre	on	the	issue	of	political	donations	from	
industry.	Donations	by	pharmaceuticals	in	both	Australia	and	the	US	have	seen	a	steady	increase	
over	 the	 past	 decade	 or	 so.	 According	 to	 Senator	 Lee	 Rhiannon	 from	 the	 Australian	 Greens	
political	party,	contributions	in	her	country	are	rising	annually	(Ferguson	and	Johnston	2010).	As	
an	 example,	 the	Pharmacy	Guild,	 a	 powerful	 lobby	 group	 for	 the	Australia‐wide	pharmacists’	
network,	increased	its	total	donations	to	political	parties	across	the	board	from	AU$153,245	in	
2013‐14	to	AU$177,971	the	following	tax	year	(Australian	Electoral	Commission	n.d.).	Australia	
also	has	one	of	the	most	lax	regulatory	systems	in	the	world	for	scrutinising	political	donations	
(McGhee	2017),	with	a	series	of	loopholes	enabling	activities	such	as	splitting	donations	via	the	
various	 branches	 of	 political	 parties	 at	 state	 and	 federal	 level,	 so	 that	 they	 come	 under	 the	
compulsory	declaration	threshold	of	AU$13,000.	This	allows	corporate	contributions	to	remain	
hidden	 and,	 consequently,	 their	 influence	 on	 policy	 decisions	 more	 difficult	 to	 detect	 and	
measure.	 Lessig	 notes	 it	 is	 the	 impact	 of	 donations	 to	 political	 parties	 by	 large	 corporations,	
‘dependency	corruption’,	that	can	have	the	most	corrupting	impact	on	public	trust	in	institutions	
and	organisations	(Lessig	2012).	The	motivation	for	industry	donations	is	rarely	altruistic	but,	
rather,	seeks	to	influence	political	decision‐making	with	the	ultimate	aim	of	strengthening	the	
relevant	market,	irrespective	of	the	nature	of	the	marketable	goods.		
	
If	the	potentially	contaminating	influence	of	money	in	policy‐making	serves	to	provoke	suspicion	
of	the	integrity	of	the	state‐pharma	relationship,	the	‘revolving	door’	practice	in	which	personnel	
cross	over	from	government	to	industry	and—though	less	often—vice	versa	(Jasso‐Aguilar	and	
Waitzkin	2011),	will	 further	exacerbate	distrust.	 In	their	investigation	into	lobbying,	Ferguson	
and	Johnston	provided	a	roll	call	of	some	of	those	involved	in	the	merry‐go‐round	of	pharma‐
politics	in	Australia:		
	
A	 former	 staffer	 with	 NSW	 senator	 Bill	 Heffernan,	 Nick	 Campbell,	 is	 executive	
director	 of	 corporate	 and	 governments	 affairs	 for	 Johnson	 &	 Johnson	 …	 David	
Miles,	 a	 former	 advisor	 in	 John	Howard’s	 office,	 is	 the	 communications	 boss	 at	
Pfizer.	 Brendan	 Shaw,	 head	 of	 Medicines	 Australia,	 the	 peak	 group	 for	 drug	
manufacturer,	previously	worked	with	the	then	minister	 for	small	business	and	
consumer	affairs	Craig	Emmerson.	Then	 there	 is	Catherine	McGovern,	a	 former	
staffer	 in	 SA	 Liberal	 senator	 Nick	 Minchin’s	 office,	 who	 now	 works	 for	
GlaxoSmithKline	…	.	(Ferguson	and	Johnston	2010:	online)	
	
This	creates	an	environment	ripe	not	only	for	conflict	of	interest,	nepotism,	turning	a	blind	eye,	
and	 other	 practices	 associated	 with	 corruption,	 but	 is	 itself	 a	 corrupted	 relationship	 which	
strengthens	 the	 hand	 both	 of	 industry	 and	 the	 state	 to	 deter	 independent	 scrutiny	 of	 their	
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activities.	This,	in	turn,	threatens	the	integrity	not	only	of	politics	but	also,	in	the	case	of	pharma,	
exacerbates	suspicion	in	critical	minds	of	the	underlying	motivation	behind	the	rhetoric	of	health	
and	healing.		
	
The	corrupt	relationship	between	state	and	industry	and	its	impact	on	vaccine	safety	constituted	
the	focus	of	Judy	Wilyman’s	PhD	thesis	at	Wollongong	University.	It	is	not	the	content	of	what,	by	
accepted	academic	standards,	was	a	rigorously	researched	piece	of	scholarship	that	concerns	us	
here	but,	rather,	the	unprecedented	hostile	response	to	her	work	from	outside	the	academy,	in	
what	was	clearly	a	deliberate	campaign	to	discredit	her	findings.		
	
Censorship	by	any	other	name	
Countering	the	popular	notion	that	it	constitutes	a	rolling	back	of	the	state,	neoliberalism	is	seen	
as	a	reconstitution	of	state	power	(Harvey	2005)	whose	political	role	has	not	been	diminished	
but,	rather,	redirected	towards	preserving	and	enhancing	the	mechanisms	of	the	market.	In	other	
words,	 ‘[o]ne	must	govern	for	the	market,	rather	than	because	of	the	market’	(Foucault	2008:	
121).	 Henry	 Giroux	 argues	 that	 neoliberalism	 has	 laid	 the	 foundations	 for	 a	 ‘growing	
authoritarianism	that	encourages	profit‐hungry	monopolies,	the	ideology	of	faith‐based	certainty	
and	 the	undermining	of	any	vestige	of	critical	education,	dissent,	and	dialog	 [emphasis	 added]’	
(2005:	151).	Authoritarianism	is	the	condition	of	absolute	state	power,	with	censorship	as	one	of	
its	most	 powerful	 tools.	 The	 draconian	 response	 to	 vaccine	 criticism	 or	 dissent	 in	 Australia,	
through	 a	 number	 of	 actions	 that	 repress	 free	 speech,	 is	 sliding	 into	 the	 realm	 of	 Giroux’s	
dystopian	fears,	as	Wilyman’s	experience	shows.		
	
Wilyman’s	 thesis,	 entitled	 ‘A	 critical	 analysis	 of	 the	 Australian	 government’s	 rationale	 for	 its	
vaccination	policy’,	became	the	target	of	an	orchestrated	character	assassination	amid	calls	for	
Wollongong	University	to	retract	her	PhD.	Her	research	comprised	a	social	scientific	study	on	the	
impact	of	various	international	partnerships	on	the	mass	vaccination	policy	adopted	in	Australia	
and	how	this	might	affect	the	safety,	efficacy	and	necessity	of	certain	vaccines.	The	thesis	provides	
a	detailed	analysis	of	 the	 relationships	between	various	policy	groups	with	 industry,	possible	
financial	 influences	 on	 decision‐making,	 and	 non‐disclosure	 by	 advisors	 of	 links	with	 vaccine	
manufacturers	that	might	skew	their	guidance	and	opinion.	She	further	emphasised	the	lack	of	
transparency	in	Australia’s	vaccine	program,	including	the	withholding	of	information	about	the	
price	of	vaccines	funded	by	public	money.	On	the	granting	of	her	thesis,	the	media,	not	known	for	
their	 interest	 in	PhD	monographs,	 subjected	her	 to	hostile	 criticism	 through	a	number	of	 the	
medical	profession,	paradoxically	granting	the	oxygen	of	publicity	to	a	study	deemed	by	them	to	
be	scientifically	unreliable.	In	The	Australian	newspaper,	Dr	John	Cunningham,	a	surgeon	rather	
than	 immunologist	 by	 specialisation	 but	 a	 spokesman	 for	 the	 pro‐vaccine	 group	 Stop	 the	
Australian	Vaccine	Network	 (SAVN),	 launched	 a	 vituperative	 attack	 against	Wilyman	 and	her	
supervisor,	describing	the	thesis	as	based	on	’bizarre	conspiracy	theories	to	explain	vaccination	
policy’	while	not	providing	any	detailed	evidence	of	what	he	considered	‘grossly	flawed’	aspects	
of	her	thesis	(Cunningham	2016).	He	went	on	to	describe	the	university’s	defence	of	academic	
freedom	 as	 ‘corporate	 narcissism’.	 (Wollongong	 University	 stood	 by	 Wilyman,	 asserting	 its	
adherence	to	protocol	during	the	examination	process,	and	refused	to	retract	the	award).		
	
Meanwhile,	Wilyman’s	primary	supervisor,	Professor	Brian	Martin,	described	by	The	Australian	
as	someone	‘with	a	long	history	of	supporting	controversial	PhD	candidates’	(Louissikian	2016),	
was	drawn	into	the	controversy.	The	attack	on	Martin	was	ironic	given	that	his	specialist	area	of	
research	is	intellectual	freedom,	whistleblowing	and	the	suppression	of	dissent.	In	a	response	to	
a	particularly	vindictive	blog	about	his	own	academic	credentials,	he	summed	up	the	motivation	
behind	 the	 attacks	 as	 based	 on	 the	 assumption	 that	 any	 ‘findings	 contrary	 to	what	 they	 [the	
mainstream]	believe	is	correct	must	be	wrong	or	dangerous	or	both’	(Martin	2017:	1).	A	proposed	
visit	to	Australia	by	another	vaccine	critic,	US	physician	Dr	Sherri	Tenpenny,	once	again	saw	John	
Cunningham	engaged	in	a	personalised	verbal	assault,	claiming	that	‘Sherri	is	one	of	the	highest‐
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profile	anti‐vaccine	liars	in	the	USA,	and	we	should	be	sending	a	strong	message	to	these	loons	
that	in	Australia	we	rely	on	facts,	science,	and	rational	and	considered	opinion	by	people	with	
expertise’	(Medew	2015),	hardly	a	rational	and	considered	opinion.	Social	media,	one	of	the	most	
virulent	sources	of	personal	attacks,	has	spawned	a	practice	known	as	‘astroturfing’,	the	creation	
of	 ‘fake	 views’	 that	 are	 supposed	 to	 represent	 the	 opinions	 of	 the	 grassroots	majority.	 It	 is	 a	
device,	as	Monbiot	explains,	used	by	the	powerful	‘to	control	and	influence	content	in	the	interests	
of	 the	 state	 and	 corporations,	 attempts	 in	 which	 money	 talks’	 (Monbiot	 2010).	 Astroturfing	
typically	involves	‘use	of	inflammatory	language’	such	as	‘crank’,	‘pseudo’	and	‘conspiracy’	against	
those	holding	counterviews	 in	which	astroturfers	 claim	 to	be	debunking	myths	when	what	 is	
being	 debunked	 is	 an	 exposed	 reality.	 Tactics	 involve	 personal	 attacks	 on	 the	 persons	 and	
organisations	 challenging	 mainstream	 narratives	 by	 focusing	 on	 those	 exposing	 wrongdoing	
rather	than	on	the	wrongdoing	being	exposed	(Atkinsson	2015).	In	a	more	recent	development,	
verbal	 attacks	 are	 being	 replaced	 by	 substantive	 punitive	measures	 against	 those	 doctors	 in	
Australia,	concerned	about	contraindications	in	vaccines,	who	have	supported	parents’	refusal	to	
vaccinate.	Now	facing	‘the	toughest	penalties	possible’	from	the	government,	John	Piesse,	one	of	
the	doctors	under	investigation	opines:	‘[t]here’s	no	freedom	of	speech	about	vaccines.	Anyone	
who	takes	a	contrary	view	is	attacked’	(Percy	and	Norman	2017).	
	
Self‐censorship	 by	 a	 market‐determined	 media	 has	 further	 embedded	 the	 dominant	 vaccine	
narrative	 as	 an	 unchallengeable	 reality	 to	 such	 an	 extent	 that	 censorship	 is	 able	 to	 subtly	
metamorphose	into	rationality.	This	has	enabled	experts	themselves	to	undermine	the	scientific	
objectivity	and	integrity	they	claim	as	fundamental	to	their	discipline	by	condemning	balanced	
opinion	and	advocating	the	very	‘ideology	of	faith‐based	certainty’	against	which	Giroux	warns.	
Consequently,	 the	 lead	 spokesperson	 for	 vaccine	 programs	 in	 the	US,	Dr	Paul	Offit,	 is	 able	 to	
comment	on	the	media	as	being	‘far	more	responsible	about	covering	this	[vaccine]	story.	If	you	
look	 at	 the	 way	 it	 was	 covered	 fifteen	 years	 ago,	 it	 was	 always	 this	 false	mantra	 of	 balance	
[emphasis	added],	which	is	to	tell	two	sides	of	the	story	when	only	one	side	is	supported	by	the	
science’	(Beyerstein	2015),	without	provoking	accusations	that	his	position	implicitly	supports	
authoritarian‐style	reporting.	 	
	
Thus,	censorship	is	transformed	into	artificial	consent,	through	the	construction	of	a	social	norm	
that	does	not	yet	exist,	 invisibly	inculcated	into	social	consciousness	as	if	 it	were	a	consensus.	
Critical	voices	are	reduced	to	irrational	ravings	(a	tactic	successfully	used	to	discredit	dissent	in	
the	Soviet	Union),	labelled	dangerous	‘conspiracy	theorists’,	thereby	eradicating	any	notion	that	
the	state	and	pharma	may	 indeed	conspire	to	cover	up	harmful	acts.	Yet,	as	 Jane	and	Fleming	
argue,	 where	 asymmetric	 power	 structures	 exist,	 the	 ‘hermeneutics	 of	 suspicion’	 which	
underpinned	many	of	the	theories	posited	by	Marx,	Nietzsche	and	Freud,	recognised	that	‘the	lust	
for	power	and	wealth	lurk	behind	the	ostensible	social	manifestations	of	beneficence	and	that	
powerful	people	will	 conspire	with	each	other	 to	serve	 these	 jealous	gods’	 (Jane	and	Fleming	
2014:	58).	The	ability	to	criticise	the	status	quo,	to	scrutinise	the	structures	of	power	without	fear	
of	 redress,	 and	 articulate	 a	 scepticism	 towards	 their	 intentions,	 is	 a	 fundamental	 principle	 of	
liberal	democracies,	an	expression	of	those	principles	that	respect	informed	consent	as	a	human	
right.	So	too	is	access	to	objective	data	upon	which	genuinely	informed	consent	rests,	a	feature	of	
free	society.	However,	here	also	the	state‐corporate	collaboration	in	neoliberal	health	delivery	
imprints	its	ideological	slant	on	so‐called	scientifically	informed	facts.	
	
How	informed	is	informed	consent?	
A	number	of	leading	voices	within	the	medical	profession	have	spoken	of	their	disquiet	around	
the	activities	of,	 and	 relationships	 that	make	up,	 the	pharmaindustry	and	 taint	 the	content	of	
medical	research.	Marcia	Angell	 former	editor‐in‐chief	of	 the	New	England	 Journal	of	Medicine	
(2005),	 Richard	 Horton,	 editor‐in‐chief	 of	 The	 Lancet	 (2004),	 David	 Healy,	 a	 practising	
psychiatrist	 and	 author	of	Pharmageddon	 (2012)	and	one	of	 the	most	popular	writers	on	 the	
subject	 of	 pharmaceuticals	 and	 the	 medical	 profession,	 Ben	 Goldacre	 (Bad	 Pharma	 2012),	
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constitute	a	growing	number	of	well‐placed	insiders	prepared	to	speak	out	against	the	abuses	in	
their	profession.	Peter	Gotzsche,	co‐founder	of	the	Nordic	branch	of	Cochrane,	an	independent,	
non‐governmental	organisation	for	the	systematic	review	of	clinical	research,	has	been	especially	
active	 in	 the	 public	 excoriation	 of	 his	 profession	 and	 its	 industry	 partners	 as	 the	 latter	
increasingly	influences	the	role	of	knowledge	production:		
	
When	robust	 research	has	 shown	 that	 a	product	 is	dangerous,	 [and]	numerous	
substandard	studies	are	produced	saying	the	opposite	…	This	doubt	industry		
is	very	effective	at	distracting	people	into	ignoring	the	harms	…	the	industry	buy		
time	while	people	continue	to	die.	This	is	corruption.	(Gotzsche	2013:	1‐2)	
	
Industry	funding	of	medical	research	has	been	steadily	increasing	in	most	Western	democracies	
(Ehrhardt	 et	 al.	 2015),	 driven	 by	 the	 neoliberal	model	 of	 outsourcing	 from	 the	 public	 to	 the	
private	 domain.	 The	 increasing	 influence	 wielded	 by	 private	 funders	 has	 resulted	 in	 the	
manipulation	of	clinical	trial	data;	the	employment	of	ghost	writers	for	medical	journals	operating	
under	 the	putative	 authorship	of	 an	 influential	 clinician	with	only	 tenuous	 links	 to	 the	actual	
research	undertaken;	payments	to	‘key	opinion’	speakers;	individuals	with	prestige	and	clout	in	
medicine	to	give	lectures	on	new	‘medical	discoveries’;	and	so	on.	This	is	particularly	evident	in	
the	dissemination	of	data.	
	
In	 the	 fast‐moving	 and	 competitive	world	 of	medical	 publishing,	 journals	 rely	 on	 advertising	
revenue	to	survive	and	thus	must	avoid	biting	the	hand	that	feeds.	Editorial	boards	are	frequently	
staffed	by	 individuals	who	have	 formed	 ties	with	 industry	either	 through	business‐sponsored	
grants	received	for	past	research	or	from	former	consultancies.	In	2010,	a	rigorous	study	on	the	
impact	of	 industry	funding	of	medical	 journals	 found	that	clinical	trials	conducted	by	industry	
were	more	likely	to	be	published	as	having	positive	results	than	those	conducted	independently.	
A	2003	 survey	 of	 clinical	 trial	 results	published	 in	 a	 leading	medical	 journal	 showed	 that,	 on	
publication,	 in	 the	 two‐thirds	 to	 three‐quarters	 of	 those	 which	 are	 industry‐funded,	 ‘the	
conclusions	 in	negative	 trials	 are	often	presented	 in	 such	 a	way	 that	 they	 appear	 to	 be	more	
positive	than	they	actually	are’	(Lundh	et	al.	2013:	3).	So	swayed	is	the	medical	publishing	world	
by	its	ties	to	industry	that	Richard	Horton,	editor‐in‐chief	of	The	Lancet,	has	declared	‘[j]ournals	
have	devolved	into	information	laundering	operations	for	the	pharmaceutical	industry’	(cited	in	
Smith	2005:	0364).		
	
Similarly,	quality	control	from	independent	regulators	in	the	interest	of	public	safety	has	been	
compromised	by	the	state‐pharma	relationship.	As	Healy	points	out,	controls	over	the	quality	and	
safety	of	pharmaceutical	products	are	largely	conducted	in‐house,	where	‘often	the	only	studies	
are	those	of	the	drug	companies	themselves,	and	these	studies,	as	one	might	expect,	all	seem	to	
point	 to	 the	 benefits	 of	 an	 ongoing	use	 of	 the	 very	 chemicals	 that	may	 in	 fact	 be	 causing	 the	
problem’	 (Healy	 2012:	 119).	 Yet,	where	 the	 state	 could	 act	 to	 remedy	bias,	 it	 takes	 a	 passive	
stance.	 Griffin	 and	 Miller	 identified	 ‘regulation	 deficiency’	 as	 a	 crucial	 factor	 in	 allowing	 the	
manufacturer,	 Purdue	 Pharma,	 to	 mislead	 and	 defraud	 clinicians	 through	 an	 aggressive	
advertising	 campaign	 for	 a	 drug.	 Regulation	 deficiency	 ‘occurs	when	 the	 government	 fails	 to	
protect	 individuals	from	societal	harm	despite	good	intentions’	(Griffin	and	Miller	2011:	223).	
This	presupposes	that	good	intentions	underpin	advisory	boards	as	a	matter	of	course.	But	the	
reduction	of	regulatory	oversight	of	corporations	has	also	extended	to	the	reduction	of	regulatory	
oversight	over	the	regulation	bodies	themselves.	The	British	Medical	 Journal	 recently	revealed	
that	the	Centers	for	Disease	Control	and	Prevention	(CDC),	the	US’s	‘independent’	health	advisory	
board,	 has	 been	 in	 receipt	 of	 regular	 donations,	 approved	 by	 Congress,	 from	 corporations	
including	Merck	 Sanofi‐Aventis	 and	 Abbott	 Laboratories.	 CDC	 has	 consequently	 been	making	
‘controversial	 recommendations	 for	 screening	 tests	 and	 drugs’,	 while	 ‘currently	 overseeing	
several	equally	controversial	studies.	Some	of	these	are	associated	with	“conditional”	industry	
funding’	(Lenzer	2015:	1‐2).		
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Conflict	of	 interest	 is	 thus	built	 into	 the	very	mechanism	set	up	 to	oversee	quality	and	safety,	
leaving	 the	 exposure	 of	 ineffective	 and	harmful	 products	 increasingly	 in	 the	 hands	 of	 the	 lay	
population.	However,	 the	 current	hegemonic	 status	of	 science	has	 legitimised	 its	 authority	 to	
dismiss	out‐of‐hand	critiques	 that	do	not	conform	with	 its	designated	parameters	of	 scientific	
thinking,	an	epistemology	which,	as	discussed	above,	is	itself	vulnerable	to	expedient	subjectivity.	
In	contrast,	voices	outside	the	compliant	scientific	community	are	denied	the	power	to	challenge	
the	 origins	 and	 flaws	 of	 medical	 knowledge	 insofar	 as	 their	 external	 location,	 which	 should	
legitimise	their	independence	as	a	scrutinising	body,	is	deemed	to	lack	authority	because	of	its	
externality.	In	other	words,	only	by	being	on	the	inside,	which	is	systemically	tied	to	the	interests	
of	the	state‐pharma	nexus,	can	one	claim	a	legitimate	voice	which,	by	definition,	must	be	devoid	
of	criticism	of	the	status	quo.	Hence,	we	see	the	emergence	of	a	state‐corporate	science	shaped	
by	and	responsive	to	a	neoliberal	ideology,	sustained	by	the	absence	of	transparency	and	critique	
while	demanding	loyalty	and	compliance	from	the	masses.		
	
Biopower	as	corruption	
Mandatory	vaccines	epitomise	what	Foucault	termed	biopolitics;	that	is,	the	exertion	of	‘power	
over	life’	through	technologies	of	control	over	somatic	citizenries	(2007).	As	Emily	Martin	claims:	
‘[a]ccepting	vaccinations	means	accepting	the	state’s	power	to	impose	a	particular	view	about	the	
body	 and	 its	 immune	 system—the	 view	 developed	 by	 medical	 science’	 (Martin	 1994:	 194).	
Therefore,	to	negatively	critique	or	dissent	from	some,	or	all,	of	vaccination	policy	is	to	reject	not	
only	medical	orthodoxy	but	also	the	power	of	the	state.	Exercising	the	right	to	informed	consent	
by	refusing	to	either	vaccinate	or	be	vaccinated—or,	 in	the	case	of	children,	to	refuse	on	their	
behalf—is	 to	 incur	 punitive	 action	 by	 the	 state	 for	 defiance	 of	 its	 will.	 Medicine	 that	 is	
phamaceuticalised	preventative	health	is	thus	politicised.		
	
The	 Nuremberg	 Code	 of	 1947	 establishes	 informed	 consent	 as	 an	 international	 norm	 for	
conducting	experiments	on	humans.	Subsequent	international	instruments	extended	the	right	to	
have	 control	over	one’s	 body	 in	 regards	 to	medical	 intervention.	During	 the	Nuremberg	 trial,	
which	gave	birth	to	the	eponymous	code,	Telford	Taylor,	the	principal	prosecutor,	commented:	
‘[i]n	the	tyranny	that	was	Nazi	Germany,	no‐one	could	give	such	consent	to	medical	agents	of	the	
State:	everyone	lived	in	fear	and	acted	under	duress’	(Taylor	1946).	In	other	words,	these	were	
not	medical	crimes	conducted	by	rogue	physicians	but,	rather,	state	violations	of	an	individual’s	
will	through	coercion	and	fear.	The	relevance	of	Taylor’s	comment	clearly	extends	beyond	the	
totalitarian	state.	Pressure	to	impose	a	citizen‐wide	policy	that	violates	its	own	principles	raises	
questions	concerning	the	viability	of	rights,	the	notion	of	informed	consent	and	the	ideological	
basis	upon	which	 the	willingness	 to	undermine	 these	principles	occurs.	This	 is	evident	 in	 the	
current	 climate	 in	 Australia	 in	which	 doctors	 supporting	 the	 right	 of	 their	 patients	 to	 refuse	
vaccines	are	subject	to	investigation;	dissenters	are	excluded	from	areas	of	social	life,	vilified	as	
pariahs;	 and	 vaccine	 critics	 from	 abroad	 are	 refused	 entry	 into	 Australian	 jurisdiction	 (as	
occurred	with	Tenpenny)	or	threatened	with	a	refusal	to	issue	future	visas	as	in	the	case	of	Polly	
Tommey,	 producer	 of	 the	 highly	 controversial	 film	 Vaxxed:	 From	 Cover	 Up	 to	 Catastrophe	
(Cunningham	2017).		
	
That	the	hardline	approach	to	vaccine	compliance	has	emerged	from	an	environment	driven	by	
state‐corporate	collaboration,	which	 is	riddled	with	conflicts	of	 interest	and	underscored	by	a	
lack	 of	 transparency	 and	open	debate,	 suggests	worrying	 levels	 of	 compromise	 and	 collusion	
between	the	state	and	pharma.	There	are	few,	if	any,	situations	in	which	the	state	has	been	able	
to	exert	such	expansive	control	over	the	bodies	of	 its	population	or	where	an	 industry	has	 its	
product	 mandated	 for	 such	 a	 wide	 range	 of	 consumers.	 For	 these	 reasons,	 the	 erosion	 of	
mechanisms	employed	to	check	concentrations	of	power—such	as	a	freedom	of	speech,	freedom	
of	 information	 and	 freedom	 of	 conscience—becomes	 a	 corrupting	 process,	 irrespective	 of	
whether	what	is	being	concealed	is	actually	corrupt.	It	confirms	what	many	have	asserted;	that,	
in	the	current	climate	of	neoliberal	governance,	the	state	is	programmed	to	protect	profits	rather	
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than	people	and,	 in	doing	so,	 is	potentially	subjecting	 its	citizens	to	widespread	harms.	Public	
health	is	no	exception.		
	
Conclusion	
If	state	power	is	about	controlling	populations,	and	corporate	power	about	profit	maximisation,	
the	vaccine	industry	feeds	both.	As	such,	more	than	any	other	area	of	public	health,	it	demands	a	
respect	for	human	rights,	for	independent	scientific	inquiry,	and	the	presence	of	an	effective	form	
of	surveillance	to	ensure	that	abuses	of	power	are	minimised	and	harms	avoided.	Indeed,	the	very	
premise	upon	which	claims	for	vaccines	is	made—that	is,	their	contribution	to	the	betterment	of	
humankind—assumes	 the	 presence	 of	 these	 conditions	 of	 rights	 and	 respect	 rather	 than	
repression	and	disdain.	The	editor	of	The	Lancet,	Richard	Horton,	states	 the	obvious,	 that	 ‘[i]t	
would	 seem	 within	 the	 spirit	 of	 scientific	 inquiry	 to	 pose	 questions	 that	 challenge	 received	
orthodoxies’	 (2015).	 On	 this	 supposition,	 Edward	 Jenner,	 the	 father	 of	 vaccines,	 was	 able	 to	
pursue	what	was	then	regarded	as	unorthodox,	controversial	and	dangerous	thinking.	He	was	
afforded	 the	 freedom	 to	 debate	 with	 his	 peers,	 to	 present	 his	 findings,	 to	 develop	 his	 ideas,	
however	contentious	they	might	have	been.	Whether	Jenner’s	science	was	right	or	wrong	is	not	
the	issue	here.	Rather,	the	fact	that	he	could	and	did	pursue	what	he	genuinely	believed	would	
make	a	contribution	to	modern	medicine	is	a	testament	to	the	spirit	of	free	inquiry	that	drives	
scientific	advancement.	So	too,	the	ability	to	choose	how	and	when	medical	intervention	can	be	
applied	 to	 an	 individual’s	 body,	 without	 fear	 of	 demonisation,	 is	 a	 testament	 to	 the	 spirit	 of	
freedom	of	 choice	and	conscience.	When	 science	 serves	 state	power,	 and	 the	 state	 serves	 the	
corporate	world,	each	becomes	corrupt	and	corrupting,	and	society	moves	one	step	closer	to	a	
repetition	of	medicine’s	darkest	time.		
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1	By	‘pharmamedicalisation’,	I	am	referring	to	the	increasing	conceptualisation	and	administration	of	health	as	relying	
on	drug‐based	responses.	‘Medicalisation’	is	a	term	used	to	describe	the	societal	trend	for	constructing	circumstances	
and	conditions	as	medical	problems.	‘Pharma’	emphasises	the	increasing	employment	of	medication	to	offer	a	cure	
for	the	growing	list	of	illnesses.		
2	Adjuvants	are	added	to	vaccines	to	augment	the	immune	response	to	the	antigens	by	stimulating	higher	 levels	of	
antibody	resistance.	The	most	common	type	of	adjuvants	are	aluminium	salts	and	emulsions	(oil	in	water,	or	vice	
versa).	Preservatives,	around	which	there	has	been	the	most	controversy,	include	thimerosal	(though	no	longer	used	
in	many	vaccines	for	young	children	because	of	safety	concerns),	formaldehyde	and	human	serum	albumin.	
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